36 results
Keyword Octreotide Remove keyword
Type of content
Events Remove Events filter
-
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 5-8 July 2021
European Medicines Agency, Amsterdam, the Netherlands, from 05/07/2021 to 08/07/2021, Last updated: 10/05/2022 -
List item
Committee for Medicinal Products for Human Use (CHMP): 20-23 June 2022 (updated)
European Medicines Agency, Amsterdam, the Netherlands, from 20/06/2022 to 23/06/2022, Last updated: 20/06/2022 -
List item
Committee for Medicinal Products for Human Use (CHMP): 16-19 May 2022
European Medicines Agency, Amsterdam, the Netherlands, from 16/05/2022 to 19/05/2022, Last updated: 16/05/2022 -
List item
Committee for Medicinal Products for Human Use (CHMP): 21-24 March 2022 (updated)
European Medicines Agency, Amsterdam, the Netherlands, from 21/03/2022 to 24/03/2022, Last updated: 31/05/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 8-11 February 2021
European Medicines Agency, Amsterdam, the Netherlands, from 08/02/2021 to 11/02/2021, Last updated: 08/02/2021 -
List item
Management Board meeting: 16-17 March 2022
European Medicines Agency, Amsterdam, the Netherlands, from 16/03/2022 to 17/03/2022, Last updated: 20/04/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 29 November-2 December 2021
European Medicines Agency, Amsterdam, the Netherlands, from 29/11/2021 to 02/12/2021, Last updated: 29/11/2021 -
List item
Committee for Orphan Medicinal Products (COMP): 3-5 November 2021
European Medicines Agency, Amsterdam, the Netherlands, from 03/11/2021 to 05/11/2021, Last updated: 06/06/2017 -
List item
Committee for Orphan Medicinal Products (COMP): 6-7 November 2012
European Medicines Agency, London, UK, from 06/11/2012 to 07/11/2012, Last updated: 31/08/2011 -
List item
Committee for Orphan Medicinal Products (COMP): 9-11 July 2013
European Medicines Agency, London, UK, from 09/07/2013 to 11/07/2013, Last updated: 08/05/2012 -
List item
Paediatric Committee (PDCO): 20-22 May 2015
European Medicines Agency, London, UK, from 20/05/2015 to 22/05/2015, Last updated: 20/05/20158 6.1.2. Octreotide (hydrochloride) - EMEA-14-2015 … -
List item
Committee for Medicinal Products for Human Use (CHMP): 17-20 March 2014
European Medicines Agency, London, UK, 17/03/2014, Last updated: 09/08/2013 -
List item
Committee for Medicinal Products for Human Use (CHMP): 23-26 June 2014
European Medicines Agency, London, UK, from 23/06/2014 to 26/06/2014, Last updated: 09/08/2013 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 5-8 March 2018
European Medicines Agency, London, UK, from 05/03/2018 to 08/03/2018, Last updated: 05/03/2018 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 8-11 March 2021
European Medicines Agency, Amsterdam, the Netherlands, from 08/03/2021 to 11/03/2021, Last updated: 27/02/2018NAP).........................................................................................................15 4.2.2. Octreotide (NAP)........................................................................................................15 … -
List item
European network of paediatric research-European Medicines Agency meeting on rare gastrointestinal and liver diseases
European Medicines Agency, London, UK, 08/12/2015, Last updated: 26/01/2016 -
List item
Committee for Orphan Medicinal Products (COMP): 8-9 April 2014
European Medicines Agency, London, UK, from 08/04/2014 to 09/04/2014, Last updated: 08/05/2012 -
List item
Committee for Orphan Medicinal Products (COMP): 14-15 March 2017
European Medicines Agency, London, UK, from 14/03/2017 to 15/03/2017, Last updated: 19/06/2014 -
List item
Committee for Orphan Medicinal Products (COMP): 19-21 April 2016
European Medicines Agency, London, UK, from 19/04/2016 to 21/04/2016, Last updated: 17/06/2014 -
List item
Committee for Orphan Medicinal Products (COMP): 4-6 October 2016
European Medicines Agency, London, UK, from 04/10/2016 to 06/10/2016, Last updated: 17/07/2014 -
List item
Committee for Orphan Medicinal Products (COMP): 3-5 October 2012
European Medicines Agency, London, UK, from 03/10/2012 to 05/10/2012, Last updated: 31/08/2011 -
List item
Committee for Orphan Medicinal Products (COMP): 5-7 December 2017
European Medicines Agency, London, UK, from 05/12/2017 to 07/12/2017, Last updated: 19/06/2014 -
List item
Committee for Orphan Medicinal Products (COMP): 14-16 February 2017
European Medicines Agency, London, UK, from 14/02/2017 to 16/02/2017, Last updated: 19/06/2014 -
List item
Committee for Orphan Medicinal Products (COMP): 16-18 January 2018
European Medicines Agency, London, UK, from 16/01/2018 to 18/01/2018, Last updated: 19/06/2014 -
List item
Committee for Orphan Medicinal Products (COMP): 17-19 May 2016
European Medicines Agency, London, UK, from 17/05/2016 to 19/05/2016, Last updated: 17/06/2014